首页> 外文期刊>Gene Therapy and Molecular Biology >Gene therapy approaches to the treatment ofhemoglobinopathies
【24h】

Gene therapy approaches to the treatment ofhemoglobinopathies

机译:基因疗法治疗血红蛋白病

获取原文
           

摘要

Hemoglobinopathies such as thalassemia and sickle cell anemia are potentially amenable to gene therapy. Applicable gene therapy strategies can be divided into four categories: those that replace the faulty gene with a complete transcriptional unit, those that activate transcription of fetal hemoglobin genes, those that modify the endogenous gene itself, and those that attempt to repair the defective globin RNA transcripts transcribed from the gene. Before becoming valuable in the treatment of human patients, each of these methodologies must overcome obstacles in efficiency of delivery, level of effectiveness, and length of time the treatment remains effective.
机译:诸如地中海贫血和镰状细胞性贫血等血红蛋白病可能适用于基因治疗。适用的基因治疗策略可以分为四类:用完整的转录单位替代有缺陷的基因的方法,激活胎儿血红蛋白基因转录的方法,修饰内源基因本身的方法以及试图修复有缺陷的球蛋白RNA的方法。从该基因转录的转录本。在对人类患者的治疗中变得有价值之前,这些方法中的每一种都必须克服分娩效率,有效性水平以及治疗持续有效时间的障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号